Parkinson’s disease (PD) is a complex neurodegenerative condition in which genetic and environmental factors interact to contribute to its etiology. Remarkable progress has been made in deciphering disease etiology through genetic approaches, but there is limited data about how environmental and genetic factors interact to modify penetrance, risk, and disease severity. Here, we provide insights into environmental modifiers of PD, discussing precedents from other neurological and non‐neurological conditions. Based on these examples, we outline genetic and environmental factors contributing to PD and review potential environmental modifiers of penetrance and clinical variability in monogenic and idiopathic PD. We also highlight the potential challenges and propose how future studies might tackle these important questions.
Effect Modification between Genes and Environment and Parkinson’s Disease Risk
September 24, 2022
Training and Networking Working Group
Effect modification between genes and environment, and Parkinson's disease risk

Training and Networking Working Group
The Training and Networking working group promotes training and networking throughout the GP2 project.
Learn more about Training and Networking Working Group Meet the authors

Assistant Professor
Ziv Gan-Or, MD, PhD
McGill | Canada

Senior Lecturer
Maria Swanberg, PhD
Lund University | Lund, Sweden
Principal Investigator
Pablo Mir, MD, PhD
Instituto de Biomedicina de Sevilla (IBIS) | Seville, Spain
More outputs and publications
Towards a Global View of Parkinson's Disease Genetics
Description Parkinson\’s disease (PD) is a global health challenge, yet historically studies of PD have taken place predominantly in European populations. Recent genetics research conducted in non-European populations has revealed novel population-specific genetic loci linked to PD risk, highlighting the importance of studying PD globally. These insights have broadened our understanding of PD etiology, which […]
Mendelian Randomization and Parkinson's Disease
Description Integrative Omics in Parkinson’s Disease provides a comprehensive understanding of the current literature on high-throughput technologies relating to discoveries for Parkinson\’s disease etiology. This emerging field uses large omics datasets to investigate the etiology of Parkinson’s disease and other forms of parkinsonism. The book traces the evolution of omics technologies from the discovery of […]